The Surprising FDA View That Sent Moderna Stock Flying
Moderna stock prices increased following positive feedback from the FDA regarding the company's mRNA influenza vaccine candidate.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has released a review appearing to align with Moderna's development of an mRNA-based influenza vaccine. This development coincides with reports that the technology expands B cell response breadth and provides protection against a diverse range of influenza strains.
Coverage from Fierce Biotech, BioSpace, and Investor's Business Daily emphasizes the current alignment between regulators and the company. Nature and Medical Xpress provide the underlying scientific context regarding the vaccine's ability to trigger broader human immune responses.
Market participants are monitoring the upcoming advisory committee meeting. Coverage does not yet specify the exact date of the adcomm grilling or the specific metrics of the stock price movement.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 93d ago.
Quick answers
Why did Moderna stock rise?
Investor's Business Daily reports the increase followed a favorable review from the FDA concerning the company's mRNA flu vaccine.
What does the science say about the vaccine?
According to Nature and Medical Xpress, the vaccine has shown potential to expand the breadth of human B cell responses and offer protection against diverse influenza strains.
What is the next step for the vaccine?
Fierce Biotech and BioSpace indicate that an advisory committee review is the next significant event.
Coverage (10)
- MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns Yahoo Finance · 93d ago
- Quick takes: Moderna mRNA flu vaccine review, NIH award for genital herpes vaccine, malaria monoclonal antibody trial CIDRAP · 93d ago
- FDA appears open to Moderna’s flu vaccine ahead of adcomm statnews.com · 93d ago
- Moderna flu shot data may support use in older adults, US FDA staff says Reuters · 93d ago
- Why Is Moderna (MRNA) Stock Soaring Today Yahoo Finance · 93d ago
- Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling Fierce Biotech · 93d ago
- mRNA-based influenza vaccine expands the B cell response breadth in humans Nature · 93d ago
- mRNA flu vaccine offers immune protection against diverse strains Medical Xpress · 93d ago
- FDA, Moderna appear aligned on mRNA flu shot heading into adcomm BioSpace · 93d ago
- The Surprising FDA View That Sent Moderna Stock Flying Investor's Business Daily · 93d ago
Topics
Related trends
FDA Announces Hand Soap Recall in 15 States—Thousands of Bottles May Contain Bacteria
An FDA-announced hand soap recall spans multiple states due to potential antibiotic-resistant bacterial contamination.
Definium's LSD-based anxiety, depression drug scores another trial win
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Experts urge FDA to set clear safety and access standards for psychedelic drugs
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Want to lower your risk of dementia? It doesn’t involve a blood test
New blood tests for Alzheimer's spark urgent medical warnings, economic shifts, and congressional legislation debates.
Dow Jones Futures: Fed Rate Hike Seen As Oil, Yields Pressure Stocks; Apple, Moderna Are New Buys
Dow Jones futures face pressure as anticipation of a Federal Reserve rate hike coincides with rising oil prices and yields.